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 TP53 and the oncogene WRAP53 are adjoining genes, producing p53-WRAP53α 
sense-antisense RNA couples. WRAP53α is indispensable for p53 mRNA regulation and p53 
induction following DNA damage. Up-regulated WRAP53β can induce neoplastic transformation 
and cancer cell survival. All these, along with the associations of WRAP53 single nucleotide 
polymorphisms with tumor incidence and prognosis, highlighted an impact in human cancers. 
Considering the importance of WRAP53 in modulating p53, and the frequent occurrence of thyroid 
cancer, we examined the association of a WRAP53 SNP (rs2287499) with thyroid cancer risk and 
prognosis among Iranian-Azeri population. 
 This research was done in Tabriz-IRAN in 2014. DNA samples obtained from 106 
patients and 196 controls were subjected to polymerase chain-reaction-based single-strand 
conformational polymorphism (PCR-SSCP) analysis. Genotypes were characterized by sequencing. 
Correlations of desired SNP with thyroid cancer as well as age, gender, involved thyroid lobe, lymph 
node metastasis, tumor type, stage, and size were estimated using Chi-square (χ2) or Fisher's exact 
tests with a P-value less than 0.05 as significant. 
rs2287499 is not associated with thyroid cancer predisposition. Except for gender, none of 
the clinicopathologic factors were significantly linked to the examined genotypes. 
 rs2287499 is not a genetic risk factor for thyroid cancer. Although rs2287499 is not 
assessable as a biomarker to predict prognosis based on clinicopathologic parameters, the 
considerable association with gender suggests that this SNP may indirectly be relevant to gender-
associated disease manifestation. Further investigations on distinct types of thyroid tumors are 
needed to fully characterize the rs2287499 status in thyroid malignancies.  
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Figure 1. The allele-specific SSCP bands o006E polyacrylamide gel and the sequencing results of rs2287499 containing amplicons. Each banding 
pattern corresponds to a specific rs2287499 genotype. ACG codon encodes arginine wherase AGG encodes glycine. 
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Table 1.Genotype and allele frequencies. 
rs2287499 Cases Controls OR (95% CI) P value 
Genotypes 
CC 79 (74.5%) 132 (67.3%) 1.41 (0.80- 2.49) 0.19 
CG 25 (23.6%) 53 (27.1%) 0.83 (0.46- 1.49) 0.51 
GG 2 (1.9%) 11 (5.6%) 0.32 (0.04- 1.58) 0.12 
Alleles 
*C 183 (86.3%) 317 (80.9%) 1.49 (0.91- 2.44) 0.09 
G 29 (13.7%) 75 (19.1%) 0.67 (0.40- 1.09) 0.09 
*C is the reference allele. Estimated relative risks with odds ratios (95% CI) and P values for association 
between rs2287499 and thyroid cancer risk. 
 
Table 2. Clinicopathological characteristics of patients and estimated P values for SNP-disease associations by clinicopathological status. 
Clinic-pathologic factors CC CG GG Total P value 
Age 
≤ 35 
> 35 
 
36 (34.0%) 
43 (40.5%) 
 
14 (13.2%) 
11 (10.4%) 
 
2 (1.9%) 
0 (0.0%) 
 
52 (49.1%) 
54 (50.9%) 
 
0.264 
Gender 
Female 
Male 
 
63 (59.4%) 
16 (15.1%) 
 
18 (17.0%) 
7 (6.6%) 
 
0 (0.0%) 
2 (1.9%) 
 
81 (76.4%) 
25 (23.6%) 
 
0.041 
Tumor Type 
PTC 
FTC 
MTC 
FTA 
 
55 (51.9%) 
2 (1.9%) 
2 (1.9%) 
20 (18.9%) 
 
14 (13.2%) 
3 (2.8%) 
0 (0.0%) 
8 (7.5%) 
 
1 (0.9%) 
0 (0.0%) 
0 (0.0%) 
1 (0.9%) 
 
70 (66.0%) 
5 (4.7%) 
2 (1.9%) 
29 (27.4%) 
 
 
0.458 
 
Tumor Stage 
Early (I & II) 
Late (III & IV) 
 
50 (58.7%) 
7 (9.3%) 
 
16 (21.3%) 
1 (1.3%) 
 
1 (1.3%) 
0 (0.0%) 
 
67 (81.3%) 
8 (10.7%) 
 
0.707 
Tumor Size 
≤ 2cm 
> 2cm 
 
25 (38.5%) 
24 (36.9%) 
 
5 (7.7%) 
10 (15.4%) 
 
1 (1.5%) 
0 (0.0%) 
 
31 (47.7%) 
34 (52.3%) 
 
0.248 
Involved Lobe 
Right 
Left 
Both 
 
30 (36.1%) 
24 (28.9%) 
10 (12.1%) 
 
11(13.3%) 
5(6.0%) 
2(2.4%) 
 
1(1.2%) 
0 (0.0%) 
0 (0.0%) 
 
42 (50.6%) 
29 (34.9%) 
12 (14.5%) 
 
 
0.785 
Lymph Node metastasis 
 
Positive 
Negative 
 
 
 
25 (34.7%) 
26 (40.6%) 
 
 
 
7 (9.7%) 
5 (7.8%) 
 
 
 
1 (1.4%) 
0 (0.0%) 
 
 
 
33 (45.8%) 
39 (54.2%) 
 
 
 
0.641 
(PTC: papillary thyroid carcinoma, FTC: follicular thyroid carcinoma, MTC: medullary thyroid carcinoma, FTA: follicular thyroid adenoma) 
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